<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ovarian Res</journal-id><journal-title>Journal of Ovarian Research</journal-title><issn pub-type="epub">1757-2215</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19187547</article-id><article-id pub-id-type="pmc">2646730</article-id><article-id pub-id-type="publisher-id">1757-2215-2-3</article-id><article-id pub-id-type="doi">10.1186/1757-2215-2-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Giallauria</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>giallauria@libero.it</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Orio</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>francescoorio@virgilio.it</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Lombardi</surname><given-names>Gaetano</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>gaetano.lombardi@unina.it</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Colao</surname><given-names>Annamaria</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>colao@unina.it</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Vigorito</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vigorito@unina.it</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Tafuri</surname><given-names>Maria Giovanna</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>domenicotafuri@inwind.it</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Palomba</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>stefanopalomba@tin.it</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Cardiac Rehabilitation Unit, University of Naples "Federico II", Naples, Italy</aff><aff id="I2"><label>2</label>Endocrinology, Faculty of Exercise Sciences, University of Naples "Parthenope", Naples, Italy</aff><aff id="I3"><label>3</label>Department of Molecular &#x00026; Clinical Endocrinology and Oncology, University of Naples "Federico II", Naples, Italy</aff><aff id="I4"><label>4</label>Teaching and Methods of Sportive Activity, Faculty of Exercise Sciences, University of Naples "Parthenope", Naples, Italy</aff><aff id="I5"><label>5</label>Department of Obstetrics and Gynaecology, University of Catanzaro "Magna Graecia", Catanzaro, Italy</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>2</day><month>2</month><year>2009</year></pub-date><volume>2</volume><fpage>3</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www.ovarianresearch.com/content/2/1/3"/><history><date date-type="received"><day>6</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>2</day><month>2</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Giallauria et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Giallauria et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Giallauria               Francesco                              giallauria@libero.it            </dc:author><dc:title>            Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Journal of Ovarian Research 2(1): 3-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1757-2215(2009)2:1&#x0003c;3&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1757-2215</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Polycystic ovary syndrome (PCOS) is an endocrine disease closely related to several risk factors for cardiovascular disease. An abnormal heart rate recovery (HRR), an easily-obtained measure derived from exercise stress test and closely related to an increased risk for cardiovascular mortality, has been recently described in PCOS women. A subclinical increase of the inflammation markers has been also observed in the PCOS. This study was designed to study the relationships between HRR and inflammatory markers in PCOS women.</p></sec><sec sec-type="methods"><title>Methods</title><p>Two-hundred forty-three young PCOS patients without known risk factors for cardiovascular risk were enrolled. All patients underwent hormonal and metabolic profile, white blood cells (WBCs) count and C-reactive protein (CRP). HRR was calculated as the difference between heart rate at peak exercise and heart rate at first minute of the cool-down period. Abnormal HRR was defined as &#x02264;18 beats/min for standard exercise testing.</p></sec><sec><title>Results</title><p>Eighty-nine out of 243 patients presented abnormal HRR. Serum CRP (1.8 &#x000b1; 0.7 vs. 1.1 &#x000b1; 0.4 mg/dl, <italic>p </italic>&#x0003c; 0.001) and WBCs (7.3 &#x000b1; 1.8 vs. 6.6 &#x000b1; 1.5 10<sup>9 </sup>cells/l, <italic>p </italic>&#x0003c; 0.001) concentrations were significantly higher in PCOS patients with abnormal <italic>versus </italic>normal HRR. HRR was significantly associated with both CRP (r = -0.33, <italic>p </italic>&#x0003c; 0.001) and WBCs (r = -0.29, <italic>p </italic>&#x0003c; 0.001), although in a stepwise multiple regression HRR resulted independently associated with CRP (beta = -0.151, p = 0.001) alone. In a logistic multivariate model, the group within the highest quartile of CRP (odds ratio 1.59, 95% CI 1.07&#x02013;2.33) was more likely to have abnormal HRR than those within the lowest quartile.</p></sec><sec><title>Conclusion</title><p>Abnormal HRR and inflammatory markers are closely associated in PCOS women acting probably in concert to increase the cardiovascular risk profile of these patients.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Mounting evidences suggest that polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disease strictly associated with long-term cardiovascular risk [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In fact, PCOS women, even at young age, have a clustering of cardiovascular risk factors [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>] suggesting that they represent a group with an increased risk for developing early-onset cardiovascular disease [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Heart rate recovery (HRR) is an easily-obtained measure derived from exercise stress test and is defined as the fall in heart rate during the first minute after maximal exercise [<xref ref-type="bibr" rid="B9">9</xref>]. The underlying mechanisms by which slow HRR after exercise is associated to an increased risk for cardiovascular mortality [<xref ref-type="bibr" rid="B10">10</xref>] are not fully understood. Because the rapid decrease in heart rate immediately after exercise is primarily due to vagal reactivation [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>], slow HRR may be indicative of decreased autonomic nervous system activity.</p><p>In a recent study, PCOS women showed slower HRR when compared to healthy controls [<xref ref-type="bibr" rid="B14">14</xref>]. Notably, slower HRR was inversely associated to body mass index (BMI) and to markers of insulin resistance, suggesting a close and complex relationship between autonomic function and glucose metabolism in PCOS women [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B14">14</xref>].</p><p>Inflammation plays a key role in the pathophysiological mechanism of atherosclerosis [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>] and cardiovascular disease [<xref ref-type="bibr" rid="B17">17</xref>]. Several inflammation markers, such as C-reactive protein (CRP), interleukin 6, soluble intercellular adhesion molecule type 1, and white blood cells (WBCs) count, are found to be significant predictors of the risk of coronary heart disease and future cardiovascular events [<xref ref-type="bibr" rid="B18">18</xref>]. Inflammation may also be associated with the metabolic syndrome [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>] and increases WBCs count [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Cross-sectional studies have suggested that cardiac autonomic nervous activity, as assessed by heart rate variability, is related to inflammatory markers such as CRP and WBCs count [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Experimental studies reported that vagal nerve stimulation can modulate inflammatory cytokines through the cholinergic anti-inflammatory pathway [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>], thus suggesting that HRR may be related to inflammatory markers.</p><p>Based on these considerations, the current study was designed to study the relationships between HRR and inflammatory markers in a population of women with PCOS.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study design</title><p>Two-hundred forty-three PCOS patients were recruited at the Department of Molecular and Clinical Endocrinology and Oncology in Naples (Italy) among those who consecutively visited the ambulatory from January 2005 to March 2008.</p><p>All PCOS patients achieved the European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine criteria for the PCOS diagnosis [<xref ref-type="bibr" rid="B26">26</xref>]. Polycystic ovaries were identified by transvaginal ultrasonography examination [<xref ref-type="bibr" rid="B26">26</xref>] and hirsutism by Ferriman-Gallwey score &#x0003e; 8.</p><p>Exclusion criteria included pregnancy, glucose intolerance [as screened by a 2-hour oral glucose tolerance test (OGTT)] and diabetes, hypothyroidism, hyperprolactinemia, Cushing's syndrome, non-classical congenital adrenal hyperplasia, and use of oral contraceptives, glucocorticoids, antiandrogens, ovulation induction agents, antidiabetic, antipsychotic and antiobesity drugs or other hormonal drugs and antihypertensive within the previous 6 months. Subjects with neoplastic, hepatic, respiratory and any cardiovascular disorder or other concurrent medical illness (i.e. respiratory and heart failure and renal disease) were also excluded from the study.</p><p>The study was conducted according to the guidelines of the Declaration of Helsinki, and the Institutional Ethical committee approved the study protocol. The purpose of the protocol was explained to each subject, and written informed consent was obtained from each patient before the screening. The study had no external funding source.</p></sec><sec><title>Biochemical Assays</title><p>All blood samples were obtained in the morning between 08.00 h and 09.00 h after an overnight fasting during the early follicular phase (2nd&#x02013;4th day) of progesterone-induced menstrual cycle. Blood samples were collected into tubes containing EDTA after a 30-min resting period in the supine position. All blood samples were immediately centrifuged at 4&#x000b0;C for 20 min at 1600 g, and stored at -20&#x000b0;C until assayed.</p><p>Plasma LH, FSH, prolactin (PRL), estradiol (E2), P, 17&#x003b1;-hydroxyprogesterone (17-OH-P), T, androstenedione (&#x00394;4), and DHEA-S levels were measured by specific radioimmunoassays (RIA) as previously described [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. The levels of SHBG were measured using an IRMA [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>], and the free androgen index (FAI) was calculated [T(nmol/l)/SHBG(nmol/l) &#x000d7; 100].</p><p>Blood insulin and glucose levels were measured by a solid-phase chemiluminescent enzyme immunoassay and the glucose oxidase method, respectively [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. The glucose and insulin areas under curve (AUC) for glucose (AUC<sub>GLU</sub>) and for insulin (AUC<sub>INS</sub>), and the AUC<sub>GLU</sub>/AUC<sub>INS </sub>ratio [<xref ref-type="bibr" rid="B27">27</xref>], in response to the OGTT were also calculated.</p><p>The lipid profile consisted of serum total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and triglycerides (TG) levels as previously described [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. WBCs count and CRP were measured as previously described [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Inter- and intra-assay coefficients of variation were &#x0003c; 5% for all blood variables.</p></sec><sec><title>Cardiopulmonary exercise test and HRR evaluation</title><p>PCOS women underwent a symptom-limited CPX with Bruce treadmill protocol [<xref ref-type="bibr" rid="B6">6</xref>]. Heart rate (HR) and blood pressure (BP) at baseline and peak exercise, heart rate 1 minute into a walking cool-down period (1.7 mph at 0% grade), and treadmill speed and grade at peak exercise were recorded as previously reported [<xref ref-type="bibr" rid="B14">14</xref>].</p><p>HRR was calculated as the difference between heart rate at peak exercise and heart rate at first minute of the cool-down period.</p><p>Abnormal HRR, determined in our population by finding the maximum value for the log-rank chi-square test statistic for all possible cutoff points across percentiles, was defined as &#x02264;18 beats/min [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Respiratory gas exchange measurements were obtained breath-by-breath with use of a computerized metabolic cart (Vmax 29C, Sensormedics, Yorba Linda, CA) as previously described [<xref ref-type="bibr" rid="B6">6</xref>].</p></sec><sec><title>Statistics</title><p>Data are expressed as mean &#x000b1; standard deviation for continuous variables and as counts and proportions for categorical variables. Two group comparisons were performed using independent Student's t tests for continuous variables and the chi-square test for categorical variables. CRP values were log transformed because of non-normal distribution. Pearson's correlations, stepwise multiple regression analysis, and analysis of variance were used to determine the relation between HRR and inflammatory markers. The selection of variables for entrance into the multivariate model was based on the univariate analysis. We tested potential collinearity among covariates using Pearson's correlations. After these evaluations, we selected the non-collinear variables for multivariable models: age, BMI, AUC<sub>INS</sub>, fasting glucose, TC, HDL-C, TG, HR<sub>REST</sub>, and VO<sub>2peak</sub>. Logistic regression was used to evaluate the association between abnormal HRR (yes or no) and quartiles of CRP and WBCs count (categorical data). Statistical significance was set at p &#x0003c; 0.05 for all data. Statistical analyses were performed using SPSS version 13.0 (SPSS, Inc., Chicago, IL).</p></sec></sec><sec><title>Results</title><p>Group comparisons according to abnormal HRR (&#x02264;18 beats/min) are listed in Table <xref ref-type="table" rid="T1">1</xref>. Abnormal HRR was found in 89 patients of 243 (36.6%). Patients with abnormal HRR had significantly greater levels of CRP (<italic>p </italic>&#x0003c; 0.001), and WBCs (<italic>p </italic>&#x0003c; 0.001), but not TC and LDL-C, than subjects with normal HRR.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Hormonal characteristics of the PCOS population according to HRR.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Variables</bold></td><td align="center"><bold>Normal HRR (n = 154)</bold><break/><bold>(&#x0003e; 18 beats/min)</bold></td><td align="center"><bold>Abnormal HRR (n = 89)</bold><break/><bold>(&#x02264;18 beats/min)</bold></td><td align="center"><bold><italic>P </italic>value</bold></td></tr></thead><tbody><tr><td align="left"><bold>Ferriman-Gallwey score</bold></td><td align="center">11.9 &#x000b1; 3.5</td><td align="center">12.1 &#x000b1; 3.4</td><td align="center">0.678</td></tr><tr><td align="left"><bold>FSH (IU/liter)</bold></td><td align="center">10.5 &#x000b1; 1.7</td><td align="center">10.1 &#x000b1; 1.6</td><td align="center">0.725</td></tr><tr><td align="left"><bold>LH (IU/liter)</bold></td><td align="center">24.2 &#x000b1; 3.3</td><td align="center">23.5 &#x000b1; 3.1</td><td align="center">0.811</td></tr><tr><td align="left"><bold>PRL (ng/ml)</bold></td><td align="center">10.5 &#x000b1; 1.3</td><td align="center">10.2 &#x000b1; 1.1</td><td align="center">0.797</td></tr><tr><td align="left"><bold>E2 (pmol/liter)</bold></td><td align="center">120 &#x000b1; 30.5</td><td align="center">118 &#x000b1; 26.1</td><td align="center">0.502</td></tr><tr><td align="left"><bold>P (nmol/liter)</bold></td><td align="center">1.2 &#x000b1; 0.4</td><td align="center">1.3 &#x000b1; 0.6</td><td align="center">0.630</td></tr><tr><td align="left"><bold>17-OHP (nmol/liter)</bold></td><td align="center">1.6 &#x000b1; 0.3</td><td align="center">1.5 &#x000b1; 0.4</td><td align="center">0.809</td></tr><tr><td align="left"><bold>T (nmol/liter)</bold></td><td align="center">2.3 &#x000b1; 0.7</td><td align="center">2.5 &#x000b1; 0.5</td><td align="center">0.649</td></tr><tr><td align="left"><bold>A (nmol/liter)</bold></td><td align="center">5.1 &#x000b1; 0.7</td><td align="center">5.3 &#x000b1; 0.9</td><td align="center">0.702</td></tr><tr><td align="left"><bold>DHEAS (&#x003bc;mol/liter)</bold></td><td align="center">4320 &#x000b1; 465</td><td align="center">4290 &#x000b1; 441</td><td align="center">0.488</td></tr><tr><td align="left"><bold>SHBG (nmol/liter)</bold></td><td align="center">27 &#x000b1; 6.2</td><td align="center">29 &#x000b1; 6.5</td><td align="center">0.549</td></tr><tr><td align="left"><bold>FAI</bold></td><td align="center">8.5 &#x000b1; 3.4</td><td align="center">8.6 &#x000b1; 3.6</td><td align="center">0.882</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: A, Androstenedione; DHEAS, dehydroepiandrosterone sulphate; E2, Estradiol; FAI, free androgen index; FSH, follicle stimulating hormone; HRR, heart rate recovery; LH, luteinizing hormone; P, progesterone; PRL, prolactin; SHBG, Sex Hormone Binding Globulin; T, testosterone; 17-OHP, 17&#x003b1;-hydroxyprogesterone.</p></table-wrap-foot></table-wrap><p>Using Pearson's correlations, HRR was significantly associated with age (r = -0.28, p &#x0003c; 0.001), BMI (r = -0.49, <italic>p </italic>&#x0003c; 0.001), AUC<sub>INS </sub>(r = -0.44, <italic>p </italic>&#x0003c; 0.001), HDL-C (r = 0.26, <italic>p </italic>&#x0003c; 0.001), TG (r = -0.28, <italic>p </italic>&#x0003c; 0.001), HR<sub>REST </sub>(r = -0.31, <italic>p </italic>&#x0003c; 0.001), VO<sub>2peak </sub>(r = 0.51, <italic>p </italic>&#x0003c; 0.001), logCRP (r = -0.33, <italic>p </italic>&#x0003c; 0.001) and WBCs (r = -0.29, <italic>p </italic>&#x0003c; 0.001). For anthropometrical, metabolic and cardiopulmonary profile of the PCOS population according to HRR, see Table <xref ref-type="table" rid="T2">2</xref>.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Anthropometrical, metabolic and cardiopulmonary profile of the PCOS population according to HRR.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Variables</bold></td><td align="center"><bold>Normal HRR (n = 154)</bold><break/><bold>(&#x0003e; 18 beats/min)</bold></td><td align="center"><bold>Abnormal HRR (n = 89)</bold><break/><bold>(&#x02264;18 beats/min)</bold></td><td align="center"><bold><italic>P </italic>value</bold></td></tr></thead><tbody><tr><td align="left"><bold>Age (years)</bold></td><td align="center">20.7 &#x000b1; 2.3</td><td align="center">23.9 &#x000b1; 1.9</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>BMI (Kg/m2)</bold></td><td align="center">27.3 &#x000b1; 2.9</td><td align="center">31.3 &#x000b1; 3.1</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>WHR</bold></td><td align="center">0.84 &#x000b1; 0.2</td><td align="center">0.87 &#x000b1; 0.1</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>TC (mg/dl)</bold></td><td align="center">153.3 &#x000b1; 18.1</td><td align="center">155.8 &#x000b1; 16.6</td><td align="center">0.442</td></tr><tr><td align="left"><bold>HDL-C (mg/dl)</bold></td><td align="center">44.2 &#x000b1; 7.3</td><td align="center">40.9 &#x000b1; 10.5</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>LDL-C (mg/dl)</bold></td><td align="center">89.5 &#x000b1; 8.3</td><td align="center">90.4 &#x000b1; 7.6</td><td align="center">0.593</td></tr><tr><td align="left"><bold>TG (mg/dl)</bold></td><td align="center">114.6 &#x000b1; 20.3</td><td align="center">122 &#x000b1; 22.4</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>Fasting glucose</bold></td><td align="center">93.0 &#x000b1; 6.8</td><td align="center">98.3 &#x000b1; 7.1</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>Fasting insulin</bold></td><td align="center">20.1 &#x000b1; 3.3</td><td align="center">24.2 &#x000b1; 3.7</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>AUC<sub>GLU</sub></bold></td><td align="center">11950 &#x000b1; 2122</td><td align="center">12033 &#x000b1; 2154</td><td align="center">0.335</td></tr><tr><td align="left"><bold>AUC<sub>INS</sub></bold></td><td align="center">16520 &#x000b1; 950</td><td align="center">17480 &#x000b1; 970</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>AUC<sub>GLU/INS</sub></bold></td><td align="center">0.77 &#x000b1; 0.2</td><td align="center">0.73 &#x000b1; 0.3</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>WBCs count (&#x000d7; 10<sup>9 </sup>cells/l)</bold></td><td align="center">6.6 &#x000b1; 1.5</td><td align="center">7.3 &#x000b1; 1.8</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>CRP (mg/dl)</bold></td><td align="center">0.11 (0.09&#x02013;0.25)</td><td align="center">0.21 (0.11&#x02013;0.69)</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>logCRP (mg/dl)</bold></td><td align="center">1.1 &#x000b1; 0.4</td><td align="center">1.8 &#x000b1; 0.7</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>HR<sub>REST </sub>(beats/min)</bold></td><td align="center">67.2 &#x000b1; 2.5</td><td align="center">72.1 &#x000b1; 3.9</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left"><bold>VO<sub>2peak </sub>(ml/Kg/min)</bold></td><td align="center">26.1 &#x000b1; 3.3</td><td align="center">22.5 &#x000b1; 2.8</td><td align="center">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AUC<sub>GLU</sub>, area under the curve for glucose; AUC<sub>INS</sub>, area under the curve for insulin; BMI, body mass index; CRP, C-reactive protein; HDL-C, high density lipoprotein cholesterol; HRR, heart rate recovery; HR<sub>REST</sub>, resting heart rate; LDL-C, low density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; VO<sub>2max</sub>, maximal oxygen consumption; WBCs, white blood cells; WHR, waist to hip ratio.</p></table-wrap-foot></table-wrap><p>In the stepwise multiple regression analysis, HRR (each 1 beat/min) was independently associated with logCRP (Table <xref ref-type="table" rid="T3">3</xref>). Subjects were divided into quartiles according to HRR (quartile 1: &#x0003c; 18 beats/min; quartile 2: 18 to 24 beats/min; quartile 3: 25 to 30 beats/min; quartile 4: &#x0003e; 30 beats/min).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Stepwise multiple regression analysis for log C-reactive protein.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Variables</bold></td><td align="left"><bold>&#x003b2; Coefficient</bold></td><td align="left"><bold>SE</bold></td><td align="left"><bold><italic>P </italic>value</bold></td></tr></thead><tbody><tr><td align="left">HRR*</td><td align="left">-0.151</td><td align="left">0.001</td><td align="left">0.001</td></tr><tr><td align="left">Fasting glucose</td><td align="left">0.039</td><td align="left">0.001</td><td align="left">0.005</td></tr><tr><td align="left">AUC<sub>INS</sub></td><td align="left">-0.136</td><td align="left">0.001</td><td align="left">0.001</td></tr><tr><td align="left">BMI</td><td align="left">0.126</td><td align="left">0.003</td><td align="left">0.001</td></tr><tr><td align="left">VO<sub>2max</sub></td><td align="left">-0.139</td><td align="left">0.001</td><td align="left">0.001</td></tr><tr><td align="left">HDL-C</td><td align="left">-0.177</td><td align="left">0.001</td><td align="left">0.001</td></tr><tr><td align="left">TG</td><td align="left">-0.141</td><td align="left">0.001</td><td align="left">0.001</td></tr><tr><td align="left">HR<sub>REST</sub></td><td align="left">0.108</td><td align="left">0.002</td><td align="left">0.001</td></tr></tbody></table><table-wrap-foot><p>Regression analysis included age, BMI, TC, HDL-C, LDL-C, TG, fasting glucose, AUC<sub>INS</sub>, HR<sub>REST</sub>, HRR, and VO<sub>2max </sub>as covariates. Abbreviations: AUC<sub>INS</sub>, area under the curve for insulin; BMI, body mass index; HDL-C, high density lipoprotein cholesterol; HR<sub>REST</sub>, resting heart rate; HRR, heart rate recovery; TC, total cholesterol; TG, triglycerides; VO<sub>2max</sub>, maximal oxygen consumption. *Each 1 beat/min.</p></table-wrap-foot></table-wrap><p>The levels of logCRP and WBCs in each quartile were 1.26 &#x000b1; 0.2, 1.13 &#x000b1; 0.2, 1.05 &#x000b1; 0.1, and 1.02 &#x000b1; 0.1 mg/dl (Figure <xref ref-type="fig" rid="F1">1</xref>) and 6.74 &#x000b1; 2.3, 6.29 &#x000b1; 1.5, 6.02 &#x000b1; 1.5, and 5.77 &#x000b1; 1.3 &#x000d7; 10<sup>9 </sup>cells/l (Figure <xref ref-type="fig" rid="F2">2</xref>) in quartiles 1 to 4, respectively. There were significant differences among quartiles 1 to 4 for logCRP (<italic>p </italic>&#x0003c; 0.05) and WBCs count (<italic>p </italic>&#x0003c; 0.05).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Mean comparison of logCRP by quartile (Q) of HRR</bold>. *Significantly different from Q4 (p &#x0003c; 0.05).</p></caption><graphic xlink:href="1757-2215-2-3-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Mean comparison of white blood cells (WBCs) count by quartile (Q) of heart rate recovery (HRR)</bold>. *Significantly different from Q4 (p &#x0003c; 0.05).</p></caption><graphic xlink:href="1757-2215-2-3-2"/></fig><p>To evaluate the association between abnormal HRR and inflammatory markers, subjects were divided into quartiles according to logCRP and WBCs count. In a logistic multivariate model (adjusted for age, BMI, TC, HDL-C, TG, fasting glucose, AUC<sub>INS</sub>, HR<sub>REST </sub>and VO<sub>2peak</sub>) the group within the highest quartile of log CRP and WBCs count was more likely to have abnormal HRR than the group within the lowest quartile of log CRP and WBCs count (Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Multivariate-adjusted odds ratios (95% confidence interval) for abnormal heart rate recovery (HRR) by quartile of log C-reactive protein (log CRP) and white blood cells (WBCs) count</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Variable</bold></td><td align="left"><bold>Quartile 1 (Reference)</bold></td><td align="left"><bold>Quartile 2</bold></td><td align="left"><bold>Quartile 3</bold></td><td align="left"><bold>Quartile 4</bold></td></tr></thead><tbody><tr><td align="left"><bold>logCRP (mg/dl)</bold></td><td align="left">(n = 67) &#x02264;0.8</td><td align="left">(n = 75) 0.81&#x02013;1.19</td><td align="left">(n = 53) 1.2&#x02013;1.5</td><td align="left">(n = 48) &#x02265;1.5</td></tr><tr><td align="left">&#x02003;Crude model</td><td align="left">1.00</td><td align="left">1.44 (1.21&#x02013;1.86)</td><td align="left">2.23 (1.73&#x02013;2.88)</td><td align="left">3.41 (2.42&#x02013;4.25)</td></tr><tr><td align="left">&#x02003;Adjusted model</td><td align="left">1.00</td><td align="left">1.19 (0.81&#x02013;1.63)</td><td align="left">1.34 (0.93&#x02013;1.99)</td><td align="left">1.59 (1.07&#x02013;2.33)</td></tr><tr><td align="left"><bold>WBCs count (&#x000d7; 109 cells/l)</bold></td><td align="left">(n = 62) &#x02264;5.0</td><td align="left">(n = 71) 5.1&#x02013;6.0</td><td align="left">(n = 58) 6.1&#x02013;7.0</td><td align="left">(n = 52) &#x02265;7.1</td></tr><tr><td align="left">&#x02003;Crude model</td><td align="left">1.00</td><td align="left">1.41 (1.14&#x02013;1.93)</td><td align="left">1.95 (1.48&#x02013;2.65)</td><td align="left">2.77 (2.19&#x02013;3.58)</td></tr><tr><td align="left">&#x02003;Adjusted model</td><td align="left">1.00</td><td align="left">1.38 (1.06&#x02013;2.12)</td><td align="left">1.33 (0.97&#x02013;1.96)</td><td align="left">1.61 (1.14&#x02013;2.46)</td></tr></tbody></table><table-wrap-foot><p>Crude model is unadjusted. Adjusted model includes age, BMI, TC, HDL-C, TG, fasting glucose, AUC<sub>INS</sub>, HR<sub>REST</sub>, and VO<sub>2peak</sub>.</p><p>Abbreviations: AUC<sub>INS</sub>, area under the curve for insulin; BMI, body mass index; CRP, C-reactive protein; HDL-C, high density lipoprotein cholesterol; logCRP, logarithmic transformation of CRP values; HR<sub>REST</sub>, resting heart rate; TC, total cholesterol; TG, triglycerides; VO<sub>2max</sub>, maximal oxygen consumption; WBCs, white blood cells.</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion</title><p>This study describes a significant association between post exercise slow HRR and increased levels of inflammatory markers in young PCOS women.</p><p>Post exercise HRR has been demonstrated as a risk factor for cardiovascular and all-cause mortality in healthy adults [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>], in individuals with CVD [<xref ref-type="bibr" rid="B30">30</xref>] in individuals with risk factors for CVD [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>] and in men with diabetes [<xref ref-type="bibr" rid="B33">33</xref>]. HRR is positively associated with insulin sensitivity as measured with a hyperinsulinemic-euglycemic clamp and metabolic syndrome in elderly men [<xref ref-type="bibr" rid="B34">34</xref>] as well as in middle-aged men and women [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B38">38</xref>].</p><p>HRR has also been found to be associated with individual components of the metabolic syndrome, such as blood glucose [<xref ref-type="bibr" rid="B36">36</xref>] low HDL-C [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>] and resting systolic and diastolic blood pressure [<xref ref-type="bibr" rid="B35">35</xref>]. Panzer <italic>et al. </italic>[<xref ref-type="bibr" rid="B36">36</xref>] demonstrated a strong inverse relationship between fasting plasma glucose and HRR even at non-diabetic levels among middle-aged healthy men and women. Moreover, HRR has been shown to be inversely associated with triglyceride/HDL-C ratio in middle-aged healthy men and women [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Although IR is not a key criterion to diagnose PCOS [<xref ref-type="bibr" rid="B26">26</xref>], there is a wide consensus that subjects with PCOS are more insulin resistant than healthy women. IR has been found to be significantly associated with impaired cardiopulmonary functional capacity [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Moreover, abnormal HRR was significantly associated to BMI and to AUC<sub>INS </sub>(a powerful marker of IR), suggesting that impaired glucose metabolism in young overweight PCOS women might be a determinant of autonomic dysfunction [<xref ref-type="bibr" rid="B14">14</xref>]. Unfortunately, the cross sectional nature of the present study does not allow the evaluation of a causal association between autonomic dysfunction and IR and the elucidation of the mechanisms involved in the pathogenesis of both conditions.</p><p>It is known that inflammation plays an important role in the development and progression of atherosclerosis [<xref ref-type="bibr" rid="B39">39</xref>], and inflammatory markers such as CRP and WBCs count are strong predictors of cardiovascular events in healthy populations as well as patients with coronary heart disease [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>Higher CRP levels and WBCs count have been described [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>] in a wide PCOS women population suggesting an increased cardiovascular risk profile in these patients [<xref ref-type="bibr" rid="B2">2</xref>]. Observational studies showed a decreased autonomic nervous system activity related to inflammatory markers [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Recent experimental evidences suggest a role for the parasympathetic nervous system in the direct regulation of inflammation, pointing to the existence of a cholinergic anti-inflammatory reflex [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Recently, Vieira <italic>et al. </italic>[<xref ref-type="bibr" rid="B41">41</xref>] reported that post exercise HRR is independently associated with lower CRP in older sedentary individuals, suggesting an involvement of parasympathetic nervous system in regulating chronic inflammation in older adults. Moreover, it has been recently reported that the reduced cardiac adrenergic activity (evaluated by iodine-123-labeled metaiodobenzylguanidine uptake) observed in patients with glucose intolerance was associated to elevated pro-inflammatory cytokine levels [<xref ref-type="bibr" rid="B42">42</xref>].</p><p>The association between autonomic nervous system and systemic inflammation in young PCOS women after adjustment for common cardiovascular and metabolic confounders shed light on the complex mechanisms and the possible therapeutic strategies related to this endocrine-cardiometabolic disease.</p><p>Experimental and clinical evidences suggest that exercise training is an effective therapeutic intervention aimed at improving autonomic function as well as cardiopulmonary functional capacity [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B45">45</xref>]. In PCOS women, the exercise-induced improvement of cardiopulmonary and autonomic function should have been addressed to the improvement in insulin sensitivity, to the reduction in BMI, and to the powerful anti-inflammatory effect of training [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>]. However, exercise training should be continued regularly in order to maintain the described beneficial effects [<xref ref-type="bibr" rid="B48">48</xref>].</p><p>Our previous prospective controlled data [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B48">48</xref>], in fact, confirmed that exercise training is effective in reducing BMI and improving insulin sensitivity markers in PCOS women, even thought no significant changes in sex hormones were observed. At this regard, it could be possible to hypothesize that the exercise induced improvement of autonomic function is mediated by BMI reduction and insulin sensitivity improvement.</p><p>Recently, Thompson <italic>et al. </italic>[<xref ref-type="bibr" rid="B49">49</xref>] studied the effect of weight loss on HRR in overweight and obese PCOS patients. After 10 weeks of diet, a significant improvement in HRR was observed in concert with a reduction in body weight, waist circumference, blood pressure, fasting insulin and glucose levels, HOMA score, T, FAI, and with an increase in SHBG [<xref ref-type="bibr" rid="B49">49</xref>]. In addition, HRR was significantly related to the reduction in body weight and waist circumference [<xref ref-type="bibr" rid="B49">49</xref>]. These findings demonstrated that weight loss can exert a beneficial role in reducing the cardiovascular risk in PCOS patients also improving the autonomic function [<xref ref-type="bibr" rid="B49">49</xref>].</p><p>Given the cross-sectional nature of the present study, it cannot be determined whether impaired autonomic function is the cause or effect of systemic inflammation. A potential limitation of our data is that we did not control for diet status, which may potentially confound the relation between HRR and inflammation markers. Because of the relation between cardiopulmonary functional capacity and HRR, strength of this study is the use of directly measured peak oxygen uptake as a covariate.</p></sec><sec><title>Conclusion</title><p>In young PCOS women, abnormal HRR after exercise testing is significantly and closely associated to inflammatory markers, i.e. CRP and WBCs. These findings could suggest that in women with PCOS several alterations could act in concert contributing to increase cardiovascular risk profile of these patients.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>FG, FO, GL, AC, CV, MGT and SP conceived of the study, participated in its design and coordination and drafted the manuscript. FG performed the statistical analysis. All authors read and approved the final version of the manuscript.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehrmann</surname><given-names>DA</given-names></name></person-group><article-title>Polycystic ovary syndrome</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>1223</fpage><lpage>1236</lpage><pub-id pub-id-type="pmid">15788499</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra041536</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Orio</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Cardiovascular risk in women with polycystic ovary syndrome</article-title><source>J Cardiovasc Med</source><year>2008</year><volume>9</volume><fpage>987</fpage><lpage>992</lpage></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>De Simone</surname><given-names>B</given-names></name><name><surname>Di Biase</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>T</given-names></name><name><surname>Labella</surname><given-names>D</given-names></name><name><surname>Zullo</surname><given-names>F</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name></person-group><article-title>Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>4588</fpage><lpage>4593</lpage><pub-id pub-id-type="pmid">15356067</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-031867</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>Di Biase</surname><given-names>S</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Tauchmanova</surname><given-names>L</given-names></name><name><surname>Nardo</surname><given-names>LG</given-names></name><name><surname>Labella</surname><given-names>D</given-names></name><name><surname>Savastano</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>T</given-names></name><name><surname>Zullo</surname><given-names>F</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name></person-group><article-title>The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15483098</pub-id><pub-id pub-id-type="doi">10.1210/jc.2004-0628</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Tauchmanov&#x000e0;</surname><given-names>L</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Di Biase</surname><given-names>S</given-names></name><name><surname>Labella</surname><given-names>D</given-names></name><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Orio</surname><given-names>F</given-names></name></person-group><article-title>Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>4395</fpage><lpage>4400</lpage><pub-id pub-id-type="pmid">16940454</pub-id><pub-id pub-id-type="doi">10.1210/jc.2006-0399</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names></name><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Vuolo</surname><given-names>L</given-names></name><name><surname>Russo</surname><given-names>T</given-names></name><name><surname>Tolino</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Cardiopulmonary impairment in young women with polycystic ovary sindrome</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>2967</fpage><lpage>2971</lpage><pub-id pub-id-type="pmid">16757529</pub-id><pub-id pub-id-type="doi">10.1210/jc.2006-0216</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>De Sio</surname><given-names>I</given-names></name><name><surname>Maresca</surname><given-names>L</given-names></name><name><surname>Vuolo</surname><given-names>L</given-names></name><name><surname>Savastano</surname><given-names>S</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name><name><surname>Orio</surname><given-names>F</given-names></name></person-group><article-title>Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome</article-title><source>Clin Endocrinol (Oxf)</source><comment></comment></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Spinelli</surname><given-names>L</given-names></name><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>Tauchmanov&#x000e0;</surname><given-names>L</given-names></name><name><surname>Zullo</surname><given-names>F</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name></person-group><article-title>The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>3696</fpage><lpage>3671</lpage><pub-id pub-id-type="pmid">15292291</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-032049</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shetler</surname><given-names>K</given-names></name><name><surname>Marcus</surname><given-names>R</given-names></name><name><surname>Froelicher</surname><given-names>VF</given-names></name><name><surname>Vora</surname><given-names>S</given-names></name><name><surname>Kalisetti</surname><given-names>D</given-names></name><name><surname>Prakash</surname><given-names>M</given-names></name><name><surname>Do</surname><given-names>D</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name></person-group><article-title>Heart Rate Recovery: Validation and Methodologic issues</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><fpage>1980</fpage><lpage>1987</lpage><pub-id pub-id-type="pmid">11738304</pub-id><pub-id pub-id-type="doi">10.1016/S0735-1097(01)01652-7</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>CR</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Pashkow</surname><given-names>FJ</given-names></name><name><surname>Snader</surname><given-names>CE</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name></person-group><article-title>Heart-rate recovery immediately after exercise as a predictor of mortality</article-title><source>N Engl J Med</source><year>1999</year><volume>341</volume><fpage>1351</fpage><lpage>1357</lpage><pub-id pub-id-type="pmid">10536127</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199910283411804</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><name><surname>Kusuoka</surname><given-names>H</given-names></name><name><surname>Ozaki</surname><given-names>H</given-names></name><name><surname>Yokoyama</surname><given-names>H</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Kamada</surname><given-names>T</given-names></name></person-group><article-title>Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure</article-title><source>J Am Coll Cardiol</source><year>1994</year><volume>24</volume><fpage>1529</fpage><lpage>1535</lpage><pub-id pub-id-type="pmid">7930286</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Saul</surname><given-names>JP</given-names></name><name><surname>Albrecht</surname><given-names>P</given-names></name><name><surname>Hartley</surname><given-names>LH</given-names></name><name><surname>Lilly</surname><given-names>LS</given-names></name><name><surname>Cohen</surname><given-names>RJ</given-names></name><name><surname>Colucci</surname><given-names>WS</given-names></name></person-group><article-title>Modulation of cardiac autonomic activity during and immediately after exercise</article-title><source>Am J Physiol Heart Circ Physiol</source><year>1989</year><volume>256</volume><fpage>132</fpage><lpage>141</lpage></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannankeril</surname><given-names>PJ</given-names></name><name><surname>Le</surname><given-names>FK</given-names></name><name><surname>Kadish</surname><given-names>AH</given-names></name><name><surname>Goldberger</surname><given-names>JJ</given-names></name></person-group><article-title>Parasympathetic effects on heart rate recovery after exercise</article-title><source>J Investig Med</source><year>2004</year><volume>52</volume><fpage>394</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">15612453</pub-id><pub-id pub-id-type="doi">10.2310/6650.2004.00611</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Vitelli</surname><given-names>A</given-names></name><name><surname>Maresca</surname><given-names>L</given-names></name><name><surname>Tafuri</surname><given-names>D</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name><name><surname>Orio</surname><given-names>F</given-names></name></person-group><article-title>Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome</article-title><source>Clin Endocrinol (Oxf)</source><year>2008</year><volume>68</volume><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17803701</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>RW</given-names></name></person-group><article-title>Inflammation and coronary artery disease</article-title><source>N Engl J Med</source><year>1994</year><volume>331</volume><fpage>468</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">8035844</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199408183310709</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Kannel</surname><given-names>WB</given-names></name><name><surname>Silbershatz</surname><given-names>H</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names></name></person-group><article-title>Clustering of metabolic factors and coronary heart disease</article-title><source>Arch Intern Med</source><year>1999</year><volume>159</volume><fpage>1104</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">10335688</pub-id><pub-id pub-id-type="doi">10.1001/archinte.159.10.1104</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CD</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Chambless</surname><given-names>LE</given-names></name><name><surname>Shahar</surname><given-names>E</given-names></name><name><surname>Wolfe</surname><given-names>DA</given-names></name></person-group><article-title>White blood cell count and incidence of coronary hart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women</article-title><source>Am J Epidemiol</source><year>2001</year><volume>154</volume><fpage>758</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">11590089</pub-id><pub-id pub-id-type="doi">10.1093/aje/154.8.758</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>M</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Baruch</surname><given-names>R</given-names></name><name><surname>Kaplan</surname><given-names>E</given-names></name><name><surname>Benjamin</surname><given-names>M</given-names></name></person-group><article-title>Leukocytes and coronary heart disease</article-title><source>Atherosclerosis</source><year>2004</year><volume>172</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14709350</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(03)00164-3</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>CC</given-names></name><name><surname>Lyall</surname><given-names>H</given-names></name><name><surname>Petrie</surname><given-names>JR</given-names></name><name><surname>Gould</surname><given-names>GW</given-names></name><name><surname>Connell</surname><given-names>JM</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name></person-group><article-title>Low grade chronic inflammation in women with polycystic ovarian syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>2453</fpage><lpage>2455</lpage><pub-id pub-id-type="pmid">11397838</pub-id><pub-id pub-id-type="doi">10.1210/jc.86.6.2453</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name></person-group><article-title>The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey</article-title><source>Atherosclerosis</source><year>2003</year><volume>168</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">12801619</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(03)00134-5</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Szklo</surname><given-names>M</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Rock</surname><given-names>R</given-names></name><name><surname>Mercuri</surname><given-names>M</given-names></name></person-group><article-title>Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study</article-title><source>Am J Epidemiol</source><year>1992</year><volume>136</volume><fpage>525</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">1442716</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sajadieh</surname><given-names>A</given-names></name><name><surname>Wendelboe Nilsen</surname><given-names>O</given-names></name><name><surname>Rasmussen</surname><given-names>V</given-names></name><name><surname>Hein</surname><given-names>HO</given-names></name><name><surname>Abedini</surname><given-names>S</given-names></name><name><surname>Jorgen</surname><given-names>FH</given-names></name></person-group><article-title>Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease</article-title><source>Eur Heart J</source><year>2004</year><volume>25</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">15033247</pub-id><pub-id pub-id-type="doi">10.1016/j.ehj.2003.12.003</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen-Urstad</surname><given-names>M</given-names></name><name><surname>Jensen-Urstad</surname><given-names>K</given-names></name><name><surname>Ericson</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>J</given-names></name></person-group><article-title>Heart rate variability is related to leukocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects</article-title><source>J Intern Med</source><year>1998</year><volume>243</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">9487329</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2796.1998.00312.x</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group><article-title>The inflammatory reflex</article-title><source>Nature</source><year>2002</year><volume>420</volume><fpage>853</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">12490958</pub-id><pub-id pub-id-type="doi">10.1038/nature01321</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borovikova</surname><given-names>LV</given-names></name><name><surname>Ivanova</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Botchkina</surname><given-names>GI</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Abumrad</surname><given-names>N</given-names></name><name><surname>Eaton</surname><given-names>JW</given-names></name><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group><article-title>Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin</article-title><source>Nature</source><year>2000</year><volume>405</volume><fpage>458</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">10839541</pub-id><pub-id pub-id-type="doi">10.1038/35013070</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><collab>Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group</collab></person-group><article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome</article-title><source>Fertil Steril</source><year>2004</year><volume>81</volume><fpage>19</fpage><lpage>25</lpage></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>MM</given-names></name></person-group><article-title>A mathematic model for the determination of total area under glucose tolerance and other metabolic curves</article-title><source>Diabetes Care</source><year>1994</year><volume>17</volume><fpage>152</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">8137688</pub-id><pub-id pub-id-type="doi">10.2337/diacare.17.2.152</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morshedi-Meibodi</surname><given-names>A</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>O'Donnell</surname><given-names>CJ</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name></person-group><article-title>Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study)</article-title><source>Am J Cardiol</source><year>2002</year><volume>90</volume><fpage>848</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">12372572</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9149(02)02706-6</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mora</surname><given-names>S</given-names></name><name><surname>Redberg</surname><given-names>RF</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Whiteman</surname><given-names>MK</given-names></name><name><surname>Flaws</surname><given-names>JA</given-names></name><name><surname>Sharrett</surname><given-names>AR</given-names></name><name><surname>Blumenthal</surname><given-names>RS</given-names></name></person-group><article-title>Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study</article-title><source>JAMA</source><year>2003</year><volume>290</volume><fpage>1600</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">14506119</pub-id><pub-id pub-id-type="doi">10.1001/jama.290.12.1600</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivekananthan</surname><given-names>DP</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Pothier</surname><given-names>CE</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name></person-group><article-title>Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>42</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">12957428</pub-id><pub-id pub-id-type="doi">10.1016/S0735-1097(03)00833-7</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>J</given-names></name><name><surname>Thamilarasan</surname><given-names>M</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Thomas</surname><given-names>JD</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name></person-group><article-title>Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>1911</fpage><lpage>1916</lpage><pub-id pub-id-type="pmid">11602493</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitsavos</surname><given-names>CH</given-names></name><name><surname>Chrysohoou</surname><given-names>C</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><name><surname>Kokkinos</surname><given-names>P</given-names></name><name><surname>Skoumas</surname><given-names>J</given-names></name><name><surname>Papaioannou</surname><given-names>I</given-names></name><name><surname>Michaelides</surname><given-names>AP</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Stefanadis</surname><given-names>CI</given-names></name></person-group><article-title>Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous familial hypercholesterolemia</article-title><source>Atherosclerosis</source><year>2004</year><volume>173</volume><fpage>347</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">15064112</pub-id><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2003.12.027</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name><name><surname>Earnest</surname><given-names>CP</given-names></name><name><surname>Church</surname><given-names>TS</given-names></name><name><surname>Kampert</surname><given-names>JB</given-names></name><name><surname>Gibbons</surname><given-names>LW</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name></person-group><article-title>Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>2052</fpage><lpage>2057</lpage><pub-id pub-id-type="pmid">12832312</pub-id><pub-id pub-id-type="doi">10.2337/diacare.26.7.2052</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Andren</surname><given-names>B</given-names></name></person-group><article-title>Heart rate recovery after exercise is related to the insulin resistance syndrome and heart rate variability in elderly men</article-title><source>Am Heart J</source><year>2002</year><volume>144</volume><fpage>666</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">12360163</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>JB</given-names></name></person-group><article-title>Metabolic syndrome is associated with delayed heart rate recovery after exercise</article-title><source>J Korean Med Sci</source><year>2006</year><volume>21</volume><fpage>621</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">16891803</pub-id><pub-id pub-id-type="doi">10.3346/jkms.2006.21.4.621</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panzer</surname><given-names>C</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name><name><surname>Brieke</surname><given-names>A</given-names></name><name><surname>Blackstone</surname><given-names>E</given-names></name><name><surname>Hoogwerf</surname><given-names>B</given-names></name></person-group><article-title>Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study</article-title><source>Diabetes</source><year>2002</year><volume>51</volume><fpage>803</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">11872683</pub-id><pub-id pub-id-type="doi">10.2337/diabetes.51.3.803</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shishehbor</surname><given-names>MH</given-names></name><name><surname>Hoogwerf</surname><given-names>BJ</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name></person-group><article-title>Association of triglyceride-to HDL Cholesterol ratio with heart rate recovery</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>936</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">15047652</pub-id><pub-id pub-id-type="doi">10.2337/diacare.27.4.936</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome</article-title><source>Clin Endocrinol (Oxf)</source><year>2007</year><volume>66</volume><fpage>152</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">17201818</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>GK</given-names></name></person-group><article-title>Inflammation, atherosclerosis, and coronary artery disease</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>1685</fpage><lpage>1695</lpage><pub-id pub-id-type="pmid">15843671</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra043430</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madjid</surname><given-names>M</given-names></name><name><surname>Awan</surname><given-names>I</given-names></name><name><surname>Willerson</surname><given-names>JT</given-names></name><name><surname>Casscells</surname><given-names>SW</given-names></name></person-group><article-title>Leukocyte count and coronary heart disease: implications for risk assessment</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>1945</fpage><lpage>1956</lpage><pub-id pub-id-type="pmid">15542275</pub-id><pub-id pub-id-type="doi">10.1016/j.jacc.2004.07.056</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>VJ</given-names></name><name><surname>Valentine</surname><given-names>RJ</given-names></name><name><surname>McAuley</surname><given-names>E</given-names></name><name><surname>Evans</surname><given-names>E</given-names></name><name><surname>Woods</surname><given-names>JA</given-names></name></person-group><article-title>Independent relationship between heart rate recovery and C-reactive protein in older adults</article-title><source>J Am Geriatr Soc</source><year>2007</year><volume>55</volume><fpage>747</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">17493195</pub-id><pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01160.x</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diakakis</surname><given-names>GF</given-names></name><name><surname>Parthenakis</surname><given-names>FI</given-names></name><name><surname>Patrianakos</surname><given-names>AP</given-names></name><name><surname>Koukouraki</surname><given-names>SI</given-names></name><name><surname>Stathaki</surname><given-names>MI</given-names></name><name><surname>Karkavitsas</surname><given-names>NS</given-names></name><name><surname>Vardas</surname><given-names>PE</given-names></name></person-group><article-title>Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation</article-title><source>Cardiovasc Pathol</source><year>2008</year><volume>17</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">18402797</pub-id><pub-id pub-id-type="doi">10.1016/j.carpath.2007.07.007</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Del Forno</surname><given-names>D</given-names></name><name><surname>Pilerci</surname><given-names>F</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>Manakos</surname><given-names>A</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Improvement of heart rate recovery after exercise training in the elderly</article-title><source>J Am Geriatr Soc</source><year>2005</year><volume>53</volume><fpage>2037</fpage><lpage>2038</lpage><pub-id pub-id-type="pmid">16274398</pub-id><pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.00479_4.x</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>Pilerci</surname><given-names>F</given-names></name><name><surname>Manakos</surname><given-names>A</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>Psaroudaki</surname><given-names>M</given-names></name><name><surname>D'Agostino</surname><given-names>M</given-names></name><name><surname>Del Forno</surname><given-names>D</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2006</year><volume>13</volume><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">16874143</pub-id><pub-id pub-id-type="doi">10.1097/01.hjr.0000216547.07432.fb</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>Pietrosante</surname><given-names>M</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>Gargiulo</surname><given-names>G</given-names></name><name><surname>D'Agostino</surname><given-names>M</given-names></name><name><surname>Gerundo</surname><given-names>G</given-names></name><name><surname>Abete</surname><given-names>P</given-names></name><name><surname>Rengo</surname><given-names>F</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Exercise-based Cardiac Rehabilitation improves Heart Rate Recovery in Elderly Patients after Acute Myocardial Infarction</article-title><source>J Gerontol Ser A-Biol Sci Med Sci</source><year>2006</year><volume>61</volume><fpage>713</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">16870634</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vigorito</surname><given-names>C</given-names></name><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Cascella</surname><given-names>T</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Lucci</surname><given-names>R</given-names></name><name><surname>De Lorenzo</surname><given-names>A</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Orio</surname><given-names>F</given-names><suffix>jr</suffix></name></person-group><article-title>Beneficial effects of a structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>1379</fpage><lpage>1384</lpage><pub-id pub-id-type="pmid">17264174</pub-id><pub-id pub-id-type="doi">10.1210/jc.2006-2794</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Maresca</surname><given-names>L</given-names></name><name><surname>Vuolo</surname><given-names>L</given-names></name><name><surname>Tafuri</surname><given-names>D</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name><name><surname>Orio</surname><given-names>F</given-names></name></person-group><article-title>Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome</article-title><source>Clin Endocrinol (Oxf)</source><year>2008</year><volume>69</volume><fpage>792</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">18505468</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2265.2008.03305.x</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orio</surname><given-names>F</given-names><suffix>Jr</suffix></name><name><surname>Giallauria</surname><given-names>F</given-names></name><name><surname>Palomba</surname><given-names>S</given-names></name><name><surname>Manguso</surname><given-names>F</given-names></name><name><surname>Orio</surname><given-names>M</given-names></name><name><surname>Tafuri</surname><given-names>D</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Carmina</surname><given-names>E</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Vigorito</surname><given-names>C</given-names></name></person-group><article-title>Metabolic and cardiopulmonary effects of detraining after a structured exercise training program in young polycystic ovary syndrome women</article-title><source>Clin Endocrinol (Oxf)</source><year>2008</year><volume>68</volume><fpage>976</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">17980005</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2265.2007.03117.x</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>RL</given-names></name><name><surname>Buckley</surname><given-names>JD</given-names></name><name><surname>Noakes</surname><given-names>M</given-names></name><name><surname>Clifton</surname><given-names>PM</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Brinkworth</surname><given-names>GD</given-names></name></person-group><article-title>Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome</article-title><source>Fertil Steril</source><year>2009</year><comment></comment></citation></ref></ref-list></back></article>